TERT and neoplasm: A significant body of evidence has demonstrated that high levels of tumour TERT expression and/or telomerase activity are significantly associated with aggressiveness of disease, advanced clinical stage, and poor OS and/or DFS in several types of tumours, including UADT SCC (13, 26, 27, 41).